PEOPLE ON THE MOVE
Sagent
Sagent Pharmaceuticals is on the hunt for a CEO after Jeffrey Yordon announced he is stepping down “to pursue my many personal interests."
Board member Fran Kung has been appointed Chairman to replace the position also vacated by Yordon.
While the company searches for a permanent Chief Executive, an interim management committee has been formed. Yordon will remain on the company’s board.
President James Hussey also announced his retirement.
Sagent, founded in 2006, develops mostly injectables and new drug delivery tech.
(Image: Northern Illinois University)